T helper (h)1/Th2 and Leishmania: Paradox rather than paradigm

Immunology Letters

Volumn 99, Issue 1, 2005, Pages 17-23

  Alexander, James ^a   Bryson, Karen ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Intracellular infection; Leishmania; Th1 Th2 paradigm

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4;

CELL PROLIFERATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; HEALING; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOBIOLOGY; INFECTION RESISTANCE; INFECTION SENSITIVITY; KNOCKOUT MOUSE; LEISHMANIA; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIASIS; MOUSE STRAIN; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SKIN DISEASE; SPECIES; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VISCERAL LEISHMANIASIS;

ANIMALS; HUMANS; INTERLEUKIN-4; LEISHMANIA; LEISHMANIASIS; TH1 CELLS; TH2 CELLS; WOUND HEALING;

EID: 19344362323     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.01.009     Document Type: Review

References (83)

1. D. McMahon-Pratt, and J. Alexander Does the Leishmania major paradigm of pathogenesis and protection hole for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 201 2004 206 224
2. S.L. Reiner, and R.M. Locksley The Regulation of immunity to Leishmania major Ann Rev Immunol 13 1995 151 177
3. P. Scott, and J.P. Farrell Experimental Cutaneous Leishmaniasis: induction and regulation of T cells following infection of mice with Leishmania major Chem Immunol 70 1998 60 80
4. D. Sacks, and C. Anderson Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice Immunol Rev 201 2004 225 238
5. J.R. Stevens, H.A. Noyes, C.J. Schofield, and W. Gibson The molecular evolution of Trypanosomatidae Adv Parasitol 48 2001 1 56
6. J. Alexander, F. Brombacher, H.A. McGachy, A.N. McKenzie, W. Walker, and K.C. Carter An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection Eur J Immunol 32 2002 2923 2933
7. A. Satoskar, H. Bluethmann, and J. Alexander Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection Infect Immun 63 1995 4894 4899
8. J. Alexander, K.C. Carter, N. Al-Fasi, A. Satoskar, and F. Brombacher Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis Eur J Immunol 30 2000 2935 2943
9. S. Stager, J. Alexander, K.C. Carter, F. Brombacher, and P.M. Kaye Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity Infect Immun 71 2003 4804 4807
10. S. Stager, J. Alexander, A.C. Kirby, M. Botto, N.V. Rooijen, D.F. Smith, F. Brombacher, and P.M. Kaye Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses Nat Med 9 2003 1287 1292
11. T. Biedermann, S. Zimmermann, H. Himmelrich, A. Gumy, O. Egeter, A.K. Sakrauski, I. Seegmuller, H. Voigt, P. Launois, A.D. Levine, H. Wagner, K. Heeg, J.A. Louis, and M. Rocken IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice Nat Immunol 2 2001 1054 1060
12. M. Mohrs, C. Holscher, and F. Brombacher Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection Infect Immun 68 2000 1773 1780
13. J. Alexander, A.R. Satoskar, and D.G. Russell Leishmania species: models of intracellular parasitism J Cell Sci 112 1999 2993 3002
14. E. Von Stebut, J.M. Ehrchen, Y. Belkaid, S.L. Kostka, K. Molle, J. Knop, C. Sunderkotter, and M.C. Udey Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice J Exp Med 198 2003 191 199
15. C.A. Dinarello The IL-1 family and inflammatory diseases Clin Exp Rheumatol 20 2002 S1 S13
16. C.L. Langrish, B.S. McKenzie, N.J. Wilson, R. de Waal Malefyt, R.A. Kastelein, and D.J. Cua IL-12 and IL-23: master regulators of innate and adaptive immunity Immunol Rev 202 2004 96 105
17. D. Artis, A. Villarino, M. Silverman, W. He, E.M. Thornton, S. Mu, S. Summer, T.M. Covey, E. Huang, H. Yoshida, G. Koretzky, M. Goldschmidt, G.D. Wu, F. de Sauvage, H.R. Miller, C.J. Saris, P. Scott, and C.A. Hunter The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity J Immunol 173 2004 5626 5634
18. C. Bogdan, A. Gessner, W. Solbach, and M. Rollinghoff Invasion, control and persistence of Leishmania parasites Curr Opin Immunol 8 1996 517 525
19. F.P. Heinzel, R.M. Rerko, and A.M. Hujer Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity Cellular Immunol 184 1998 124 142
20. U.M. Padigel, N. Kim, Y. Choi, and J.P. Farrell TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice J Immunol 161 2003 5437 5441
21. A.C. Cunningham Parasite adaptive mechanisms in infection by Leishmania Exp Molec Pathol 72 2002 132 141
22. S.B. Mannheimer, J. Hariprashad, M.Y. Stoeckle, and H.W. Murray Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor FEMS Immunol Med Microbiol 14 1996 59 61
23. D. Xu, S.J. McSorley, L. Tetley, S. Chatfield, G. Dougan, W.L. Chan, A. Satoskar, J.R. David, and F.Y.J. Liew Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium Immunology 160 1998 1285 1289
24. S. Juttner, J. Bernhagen, C.N. Metz, M. Rollinghoff, R. Bucala, and A. Gessner Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha J Immunol 161 1998 2383 2390
25. A. Diefenbach, H. Schindler, N. Donhauser, E. Lorenz, T. Laskay, J. MacMicking, M. Rollinghoff, I. Gesser, and C. Bogdan Type I interferon (IFNα/β) and type-2 nitric oxide synthase regulate the innate immune response to a protozoan parasite Immunity 8 1998 77 87
26. L. Soong, J.C. Xu, I.S. Grewal, P. Kima, J. Sun, B.J. Longley Jr., N.H. Ruddle, D. McMahon-Pratt, and R.A. Flavell Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection Immunity 4 1996 263 273
27. K.A. Campbell, P.J. Ovendale, M.K. Kennedy, W.C. Fanslow, S.G. Reed, and C.R. Maliszewski CD40 ligand is required for protective cell-mediated immunity to Leishmania major Immunity 4 1996 286 289
28. M. Kamanaka, P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity Immunity 4 1996 275 281
29. L.U. Buxbaum, J.E. Uzonna, M.H. Goldschmidt, and P. Scott Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent Eur J Immun 32 2002 3206 3215
30. F. Aguilar Torrentera, J.D. Laman, M. Van Meurs, L. Adorini, E. Muraille, and Y. Carlier Endogenous interleukin-12 is critical for controlling the late but not the early stage of Leishmania mexicana infection in C57BL/6 mice Infect Immun 70 2002 5075 5080
31. + regulatory T cells control Leishmania major persistence and immunity Nature 420 2002 502 507
32. F.P. Heinzel, M.D. Sadick, B.J. Holaday, R.L. Coffman, and R.M. Locksley Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets J Exp Med 169 1989 59 72
33. + T cells which are NK1.1 Eur J Immunol 25 1995 3298 3307
34. + T cells resulting in a state of unresponsiveness to IL-12 J Immunol 161 1998 6156 6163
35. P. Scott, A. Eaton, W.C. Gause, X. di Zhou, and B. Hondowicz Early IL-4 production does not predict susceptibility to Leishmania major Exp Parasitol 84 1996 178 187
36. M. Kopf, F. Brombacher, R. Kohler, G. Kienzle, K.H. Widmann, K. Lefrang, B. Humborg, B. Lederman, and W. Solbach IL-4 deficient mice resist infection with Leishmania major J Exp Med 184 1996 1127 1136
37. N. Noben-Trauth, P. Kropf, and I. Muller Susceptibility to Leishmania major infection in interleukin-4-deficient mice Science 271 1996 987 990
38. P. Kropf, S. Herath, V. Weber, M. Modolell, and I. Muller Factors influencing Leishmania major infection in IL-4-deficient BALB/c mice Parasite Immunol 25 2003 439 447
39. + T cells during initiation of infection J Exp Med 179 1994 447 456
40. M.L. Guler, J.D. Gorham, C.S. Hsieh, A.J. Mackey, R.G. Steen, W.F. Dietrich, and K.M. Murphy Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development Science 271 1996 984 987
41. P. Kropf, R. Etges, L. Schopf, C. Chung, J. Sypek, and I. Muller Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4 J Immunol 159 1997 3434 3443
42. Y. Belkaid, B. Butcher, and D.L. Sacks Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells Eur J Immunol 28 1998 1389 1400
43. D. Jones, M.M. Elloso, L. Showe, D. Williams, G. Trinchieri, and P. Scott Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major Infect Immun 66 1998 3818 3824
44. + T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells J Exp Med 198 2003 201 209
45. A.R. Satoskar, M. Okano, S. Connaughton, A. Raisanen-Sokolwski, J.R. David, and M. Labow Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice Eur J Immunol 28 1998 2066 2074
46. T.B. Oriss, S.A. McCarthy, B.F. Morel, M.A. Campana, and P.A. Morel Crossregulation between T helper cell (Th) 1 and Th2: inhibition of Th2 proliferation by IFN-γ involves interference with IL-1 J Immunol 158 1997 3666 3672
47. U. Eriksson, M.O. Kurrer, I. Sonderegger, G. Iezzi, A. Tafuri, L. Hunziker, S. Suzuki, K. Bachmaier, R.M. Bingisser, J.M. Penninger, and M. Kopf Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis J Exp Med 197 2003 323 331
48. B.D. Hondowicz, T.M. Scharton-Kersten, D.E. Jones, and P. Scott Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response J Immunol 159 1997 5024 5031
49. R. Nishikomori, S. Gurunathan, K. Nishikomori, and W. Strober BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling J Immunol 166 2001 6776 6783
50. + T cell-intrinsic mechanism J Exp Med 188 1998 2289 2299
51. R.A. Maldonado, D.J. Irvine, R. Schreiber, and L.H. Glimcher A role for the immunological synapse in lineage commitment of CD4 lymphocytes Nature 431 2004 527 532
52. M. Mohrs, B. Ledermann, G. Kohler, A. Dorfmuller, A. Gessner, and F. Brombacher Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling J Immunol 162 1999 7302 7308
53. N. Noben-Trauth, W.E. Paul, and D.L. Sacks IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains J Immunol 162 1999 6132 6140
54. D.J. Matthews, C.L. Emson, G.J. McKenzie, H.E. Jolin, J.M. Blackwell, and A.N. McKenzie IL-13 is a susceptibility factor for Leishmania major infection J Immunol 164 2000 1458 1462
55. N. Noben-Trauth, R. Lira, H. Nagase, W.E. Paul, and D.L. Sacks The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major J Immunol 170 2003 5152 5158
56. M.M. Kane, and D.M. Mosser The role of IL-10 in promoting disease progression in leishmaniasis J Immunol 166 2001 1141 1147
57. P. McGuirk, and K.H. Mills Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases Trends Immunol 23 2002 450 455
58. J.J. Letterio, and A.B. Roberts Regulation of Immune Response by TGF-β Ann Rev Immunol 16 1998 137 161
59. A. Gumy, J.A. Louis, and P. Launois The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds Int J Parasitol 34 2004 433 444
60. D.E. Jones, L.U. Buxbaum, and P. Scott IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection J Immunol 165 2000 364 372
61. S.G. Reed TGF-β in infections and infectious diseases Microb Infect 1 1999 1313 1325
62. Y. Belkaid, K.F. Hoffmann, S. Mendez, S. Kamhawi, M.C. Udey, T.A. Wynn, and D.L. Sacks The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure J Exp Med 194 2001 1497 1506
63. F. Aguilar Torrentera, J.D. Laman, M. Van Meurs, L. Adorini, E. Muraille, and Y. Carlier Endogenous interleukin-12 is critical for controlling the late but not the early stage of Leishmania mexicana infection in C57BL/6 mice Infect Immun 70 2002 5075 5080
64. J.C. Mottram, G.H. Coombs, and J. Alexander Cysteine peptidases as virulence factors of Leishmania Curr Opin Microbiol 7 2004 375 381
65. A. Satoskar, F. Brombacher, W.J. Dai, I. McInnes, F.Y. Liew, J. Alexander, and W. Walker SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis J Immunol 159 1997 5005 5013
66. J. Alexander, and A.R. Satoskar Leishmaniasis: does IL-13 play a significant role in the disease process? Brombacher Interleukin-13 2003 Landes Bioscience 25 38
67. U.M. Padigel, J. Alexander, and J.P. Farrell The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis J Immunol 171 2003 3705 3710
68. K.G. Pollock, K.S. McNeil, J.C. Mottram, R.E. Lyons, J.M. Brewer, P. Scott, G.H. Coombs, and J. Alexander The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses J Immunol 170 2003 1746 1753
69. J. Alexander, G.H. Coombs, and J.C. Mottram Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response J Immunol 161 1998 6794 6801
70. L.M. Stamm, A. Raisanen-Sokolowski, M. Okano, M.E. Russell, J.R. David, and A.R. Satoskar Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis J Immunol 161 1998 6180 6188
71. D.E. Jones, L.U. Buxbaum, and P. Scott IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection J Immunol 165 2000 364 372
72. L.U. Buxbaum, D. Hubert, G.H. Coombs, J. Alexander, J.C. Mottram, and P. Scott CPB cysteine proteases of Leishmania mexicana inhibit host Th1 responses and protective immunity J Immunol 171 2003 3711 3717
73. P. Cameron, A. McGachy, M. Anderson, A. Paul, G.H. Coombs, J.C. Mottram, J. Alexander, and R. Plevin Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway J Immunol 173 2004 3297 3304
74. S. De Souza Leao, T. Lang, E. Prina, R. Hellio, and J.C. Antoine Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells J Cell Sci 108 1995 3219 3231
75. E. Prina, C. Jouanne, S. de Souza Lao, A. Szabo, J.G. Guillet, and J.C. Antoine Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes J Immunol 151 1993 2050 2061
76. P.M. Kaye, A.J. Curry, and J.M. Blackwell Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis J Immunol 146 1991 2763 2770
77. M. Kemp, J.A. Kurtzhals, K. Bendtzen, L.K. Poulsen, M.B. Hansen, D.K. Koech, A. Kharazmi, and T.G. Theander Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis Infect Immun 61 1993 1069 1073
78. C.R. Engwerda, M.L. Murphy, S.E. Cotterell, S.C. Smelt, and P.M. Kaye Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani Eur J Immunol 28 1998 669 680
79. M.L. Murphy, U. Wille, E.N. Villegas, C.A. Hunter, and J.P. Farrell IL-10 mediates susceptibility to Leishmania donovani infection Eur J Immunol 31 2001 2848 2856
80. C.L. Karp, S.H. el-Safi, T.A. Wynn, M.M. Satti, A.M. Kordofani, F.A. Hashim, M. Hag-Ali, F.A. Neva, T.B. Nutman, and D.L. Sacks In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma J Clin Invest 91 1993 1644 1648
81. A. Somanna, V. Mundodi, and L. Gedamu Functional analysis of cathepsin B-like cysteine proteases from Leishmania donovani complex. Evidence for the activation of latent transforming growth factor beta J Biol Chem 277 2002 25305 25312
82. M.E. Wilson, B.M. Young, B.L. Davidson, K.A. Mente, and S.E. McGowan The importance of TGF-beta in murine visceral leishmaniasis J Immunol 161 1998 6148 6155
83. K.C. Carter, G. Gallagher, A.J. Baillie, and J. Alexander The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatment Eur J Immunol 19 1989 779 782